Store
The IVD Market in South Korea, 2024
Publication Date: February 26, 2024
Tags: APAC, Asia, Clinical Chemistry, Cytology, Diagnostics Market Research, Histology, Immunoassay, Korea, Microbiology, Molecular Testing, POC, Point-of-Care (POC) Diagnostics, South Korea
Pages: 70
SKU: 24-013
Gain valuable insights into South Korea’s in vitro diagnostics (IVD) market with Kalorama Information’s comprehensive report, The IVD Market in South Korea, 2024. We offer a detailed analysis of South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into key categories such as clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Our report also includes trends influencing the industry and country-level data, including disease incidence, life expectancy, population demographics, economic status, healthcare utilization, and other market influences.
Stay ahead of the competition with our in-depth analysis of South Korea’s IVD market. Order now to receive valuable insights that can help drive your business forward!
Key Segments Covered:
- Clinical Chemistry: Includes routine lab testing, urinalysis, blood chemistry testing, hematology, and hemoglobin tests.
- Immunoassays: Covers hormones, thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology, and common infectious diseases.
- Microbiology and Molecular Testing: Includes manual and automated tests, culture media, transport media, blood culture, sensitivity discs, and nucleic acid testing.
- Point-of-Care Testing: Encompasses POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases, blood gas, electrolytes, and glucose self-monitoring tests.
- Histology/Cytology: Covers PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
Scope:
Our report is based on primary and secondary research conducted between January 2024 and February 2024. We interviewed industry participants, government officials, medical device regulators, distributors, healthcare providers, and global market participants. Secondary data sources included government databases, company literature, medical journals, and reports. All market data pertains to the South Korean IVD market at the manufacturers’ level, with data for 2023 and forecasts up to 2028 provided. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period.
Why Choose Our Report:
- Comprehensive Overview: Get a detailed analysis of South Korea’s IVD market and the factors shaping it.
- Industry Trends: Stay informed about the latest trends influencing the IVD market in South Korea.
- Strategic Insights: Use our data to make informed decisions and develop effective strategies for your business.
Table: South Korea In Vitro Diagnostic Sales, by Extracted Market Segment, 2023-2028 (in millions $)
| Segment | 2023 | 2028 | CAGR |
| General Chemistry | $XX Million | $XX Million | XX% |
| Blood Gas Analysis | $XX Million | $XX Million | XX% |
| Urinalysis | $XX Million | $XX Million | XX% |
| Hematology | $XX Million | $XX Million | XX% |
| Hemoglobin | $XX Million | $XX Million | XX% |
| Infectious Disease Immunoassays | $XX Million | $XX Million | XX% |
| Non-infectious Disease Immunos | $XX Million | $XX Million | XX% |
| Blood Bank Screening Immunoassays | $XX Million | $XX Million | XX% |
| POC Glucose | $XX Million | $XX Million | XX% |
| POC Infectious Disease | $XX Million | $XX Million | XX% |
| POC Other | $XX Million | $XX Million | XX% |
| ID/AST | $XX Million | $XX Million | XX% |
| Microbiology Molecular | $XX Million | $XX Million | XX% |
| Blood Screening NAT | $XX Million | $XX Million | XX% |
| HPV | $XX Million | $XX Million | XX% |
| CTC | $XX Million | $XX Million | XX% |
| Other Histology | $XX Million | $XX Million | XX% |
| Others | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Industry Overview
Scope and Methodology
South Korea IVD Market Summary
- Figure 1-1: South Korea In Vitro Diagnostic Sales by Market Segment, 2023-2028 ($M)
Company Profiles
Chapter 2: South Korea Overview
Population
- Table 2-1: Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (million persons)
- Figure 2-1: Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (million persons)
- Figure 2-2: Total Number of Births in South Korea, by Year, 1990-2010 and Forecast 2020-2050
- Figure 2-3: South Korea Life Expectancy at Birth in Years, 2010-2050
Health Indicators
General Health
Disease Profiles in South Korea
- Table 2-2: Number of Deaths Attributed to Non-Communicable Diseases, by Type of Disease, All Sexes, 2019
- Table 2-3: Top 5 Cancers Affecting South Korean Population (ranked by total number of cases), 2020
- Figure 2-4: Tuberculosis – New and Relapse Case Notifications, 2000-2021
Economy and Health Spending
- Figure 2-5: South Korea GDP, GDP (PPP) and Health Spending, 1990-2020 ($B)
- Figure 2-6: South Korea Distribution of Income or Consumption by Quintile, 2011-2016
Health Infrastructure
- Figure 2-7: Healthcare System in Korea
Medical Facilities
Hospital Bed Density
- Figure 2-8: Hospital Bed Density per 1,000 Population, by Country, 2023 Estimates
Physicians
- Figure 2-9: Physician Density per 1,000 Population, by Country, 2023 Estimates
Medical Tourism
- Figure 2-10: South Korea Medical Tourism Visits Reported, 2009-2021 (# of patients)
Medical Device Regulation
- Figure 2-11: Medical Device Approval Process, South Korea
Regulatory News
Precision Medicine and NGS
Physician Shortage in South Korea
- Table 2-4: Market Divers and Inhibitors for Entering South Korea’s Medical Device Market
- Figure 2-12: South Korea Medical Device Market Growth as a Global Comparison, 2023-2028 CAGR (%)
Chapter 3: IVD Markets in South Korea
Market Summary
- Table 3-1: South Korea In Vitro Diagnostic Sales, by Extracted Market Segment (Blood Bank Screening Immunoassays, Blood Gas Analysis, Blood Screening NAT, CTC, General Chemistry, Hematology, Hemoglobin, HPV, ID/AST, Infectious Disease Immunoassays, Microbiology Molecular, Non-infectious Disease Immunos, Other Histology, POC Glucose, POC Infectious Disease, POC Other, Urinalysis, Others), 2023-2028 ($M)
- Figure 3-1: South Korea In Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, POC, Other), 2023-2028 ($M)
- Figure 3-2: South Korea In Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, POC, Other), 2023 Market Distribution (%)
Clinical Chemistry
Hematology
Hemoglobin
Blood Gas Analysis
Urinalysis
- Figure 3-3: South Korea – Clinical Chemistry Market (Blood Gas Analysis, General Chemistries, Hematology, Hemoglobin, Urinalysis), 2023-2028
Immunoassay
Non Infectious Disease Immunoassays
Infectious Disease Immunoassays
- Figure 3-4: South Korea Immunoassay Infectious Disease Market Distribution, by Disease (Blook Bank Screening Immunos, HAIs/Sepsis, Hepatitis, HIV, Mycology, Parasitology, Respiratory [w/ COVID], STD, ToRCH, Other [EBV, Chagas, Dengue, Malaria, etc.]), 2023 (%)
Blood Bank Screening Immunoassays
- Figure 3-5: South Korea – Immunoassay Market Value, by Segment (Blood Bank Screening, Infectious Disease, Non-infectious Disease), 2023-2028 ($M)
Microbiology/Molecular
ID/AST
- Figure 3-6: South Korea ID/AST Manual, Auto Market Distribution, 2023 (%)
Molecular Diagnostics
- Figure 3-7: South Korea Molecular Infectious Disease Market Distribution, by Segment (Molecular Blood Screening – NAT, Molecular HAI [c. diff/sepsis, MRSA, VRE, others], Molecular Hepatitis, Molecular HIV, Molecular Mycobacteria/TB, Molecular Other Microbiology, Molecular STD, Respiratory w/ COVID), 2023 (%)
Blood Screening
- Figure 3-8: South Korea Microbiology/Molecular Testing Market Value, by Segment (Blood Screening-NAT, ID/AST, Molecular Dx), 2023-2028 ($M)
Point-of-Care
POC Glucose
POC Infectious Disease
- Figure 3-9: South Korea POC Market Value, by Segment (Glucose, Infectious Disease, Other POC), 2023-2028 ($M)
Histology
HPV
CTC
- Figure 3-10: South Korea – Histology Market (HPV, CTC, Others), 2023-2028 ($M)
Chapter 4: Major Market Participants
Abbott Laboratories
- Table 4-1: Abbott Corporate Summary
Company Overview
Becton Dickinson (BD)
- Table 4-2: BD Corporate Summary
Company Overview
Bertis, Inc
- Table 4-3: Bertis Corporate Summary
Company Overview
bioMerieux SA
- Table 4-4: bioMerieux SA Corporate Summary
Company Overview
Bio-Rad Laboratories Inc.
- Table 4-5: Bio-Rad Labs Corporate Summary
Company Overview
Danaher Corporation
- Table 4-6: Danaher Corporation Summary
Company Overview
Fujirebio Inc
- Table 4-7: Fujirebio Corporate Summary
Company Overview
Gencurix
- Table 4-8: Gencurix Corporation Summary
Company Overview
Roche Diagnostic Corporation
- Table 4-9: Roche Diagnostic Corporate Summary
Company Overview
SD Biosensor
- Table 4-10: SD Biosensor Corporate Summary
Company Overview
Seegene, Inc.
- Table 4-11: Seegene Corporate Summary
Company Overview
Siemens Healthineers GmbH
- Table 4-12: Siemens Healthineers Corporate Summary
Company Overview
Sugentech
- Table 4-13: Sugentech Corporate Summary
Company Overview
Sysmex Corporation
- Table 4-14: Sysmex Corporate Summary
Company Overview
Thermo Fisher Scientific
- Table 4-15: Thermo Fisher Corporate Summary
Company Overview
Related products
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
Price range: $3,000.00 through $4,500.00
The World Market for Veterinary Diagnostics, 7th Edition
January 22, 2024
Unlock the potential of the veterinary diagnostics market with Kalorama Information’s comprehensive report, The World Market for Veterinary Diagnostics, 7th Edition, which dives deep into the world of animal healthcare diagnostics. From disease identification to monitoring, veterinarians rely on a variety of tests for accurate diagnoses and effective treatment plans. Our report provides a detailed…
Price range: $5,000.00 through $7,875.00
The World Market for Vaccines, 2024
February 22, 2024
Vaccines are a cornerstone of preventive medicine, offering long-term or permanent immunity against diseases. They have been instrumental in near-eliminating many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Kalorama Information’s latest report, The World Market for Vaccines, 2024, provides a comprehensive analysis of adult…
Price range: $5,000.00 through $7,875.00
